HealthBeacon Opens New Production Facility
Irish digital health technology company HealthBeacon has officially opened its newly expanded Irish headquarters in Dublin 12. HealthBeacon has been on an upward trajectory since founding in 2014, with 2018 their busiest year yet.
Over the past four years the innovative Irish medtech company has experienced comprehensive market penetration within Ireland, witnessing in excess of 100% market growth. HealthBeacon has doubled staffing over the last 18 months, now employing 30. With offices in Ireland, Canada and the US, the business operates across 10 markets from the Headquarters in Dublin. The company was recently granted FDA (US Food and Drugs Administration) clearance and launched into the US market, which is worth hundreds of millions of dollars.
HealthBeacon develops smart tools for managing medication. The ‘Smart Sharps bin’, designed for injectable medication management, tightly monitors patients digitally, keeping them adherent to their prescription and leveraging real time data to drive clinical intervention. The stand-alone device is bringing MedTech into the ‘heart of the home’ helping to address one of the biggest unmet needs within the health arena – tracking patient’s real time usage and supporting chronic medicine schedules are maintained.
The expansion of HealthBeacon HQ makes way for advanced manufacturing processes and accommodate their growing data science team. The ground-breaking Irish company growth has been driven by global demand from the pharmaceutical industry and as such is increasing the technical capacity, customer care, warehouse and manufacturing space for both the production and the product development teams.
Jim Joyce, CEO of HealthBeacon, said: “2018 has been a fast track year for HealthBeacon and today reflects our successes and our ongoing continued investment here in Ireland, our global HQ. The company has entered multiple new markets this year and received FDA clearance allowing us to enter the US market, with the world’s only Smart Sharps Adherence Platform. Looking forward we are committed to continuing contributing to Ireland’s reputation as a global leader offering innovative best in class healthcare solutions,.”
The HealthBeacon system has been clinically reviewed, validated by the pharmaceutical industry and has been integrated into thousands of patients homes throughout North America and Europe, delivering valuable data to both the patient and their clinical team.
HealthBeacon is on the forefront of the Digital Therapeutic development frontier and will be advancing its unique product development using AI technology. The team are excited to start their next chapter of new product development.
HealthBeacon has worked closely with Enterprise Ireland since founding. Terence O’Rourke, Chairman, Enterprise Ireland, said:
“Working closely with Enterprise Ireland since 2014, HealthBeacon is designing and developing digital tools that impact positively on the lives of patients worldwide. The thriving Irish medtech sector continues its story of success and the development of innovative products such as the Smart Sharp Bin contribute significantly to Ireland’s reputation as a global leader in healthcare solutions. Our aim at Enterprise Ireland is to help businesses with global ambition to build scale and expand reach, and we will continue to work with HealthBeacon as it delivers medical solutions through innovation, underpinning the company’s continued growth in world markets.”
CAPTION:
Pictured with the HealthBeacon Smart Sharp Bin device are (l-r): Eileen Bell, Senior Development Advisor, Enterprise Ireland; Jim Joyce, CEO, HealthBeacon; Kieran Daily, CTO, HealthBeacon; and Terence O’Rourke, Chairman, Enterprise Ireland.
